SPECIAL NOTICE
We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
16 April 2021
| Name: | MESOBLAST LIMITED (MSB) |
| ISIN: | AU000000MSB8 |
| Date of Listing: | 16 December 2004 |
Stock Exchange Status: (updated daily)
This entity is currently listed and quoted on the Australian Securities Exchange.Legal Status: (updated monthly)
ACN: 109 431 870ABN: 68 109 431 870
Registration Date: 08 June 2004
Capital Gains Tax (CGT) Status: (updated at least quarterly)
To crystallise a capital gain or capital loss on your securities in this entity, you are able to sell your securities on-market in the normal manner. If you determine that the market in your securities is illiquid and you still wish to crystallise a capital gain or loss, kindly contact deListed at admin@delisted.com.au for suggestions as to how you might proceed.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
Link Market Services, Tower 4, 727 Collins Street Docklands VIC 3008
Tel : +61 3 9615 9800Expand this box to read and print
The securities of Mesoblast Limited (the "Company") will be reinstated to quotation immediately, following the release of an announcement by the Company. | 14/06/2016 |
The company provides an update on its global heart failure program. | 14/06/2016 |
The company advises that the suspension of trading in its securities will remain in place pending an announcement regarding material corporate developments with respect to certain assets of the Company. The Company expects the voluntary suspension to remain in place until the earlier of the commencement of trading on 14 June 2016 and the Company making an announcement with respect to the corporate developments. | 10/06/2016 |
The securities of Mesoblast Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company. | 03/06/2016 |
The securities of Mesoblast Limited (the "Company") will be reinstated to quotation immediately, following the release of an announcement by the Company. Security Code: MSB | 16/11/2015 |
Mesoblast Limited (ASX:MSB; NASDAQ:MESO) today announced it had listed on the Nasdaq Global Market on 13 November under the symbol "˜MESO | 16/11/2015 |
Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today announced that it has filed a US registration statement on Form F-1 with the U.S. Securities and Exchange Commission, offering 5,742,510 American Depositary Shares (ADSs) in the United States, with each ADS representing five fully paid ordinary shares of Mesoblast (Shares). The actual number of ADSs and the issue price, in U.S. dollars, will be determined by Mesoblast in conjunction with the Company's underwriters at the conclusion of the offer process. | 03/11/2015 |
Mesoblast Limited (ASX: MSB, USOTC: MBLTY) announced today that it plans to conduct a registered initial public offering in the United States. Mesoblast has previously submitted to the U.S. Securities and Exchange Commission (the "SEC") a draft registration statement. Mesoblast intends to publicly file its registration statement with the SEC and commence the offering next week. | 30/10/2015 |
The company lodges its quarterly report. | 30/10/2015 |
The securities of Mesoblast Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company. Security Code: MSB | 30/10/2015 |
shares reinstated to quotation | 12/05/2010 |
the securities of Mesoblast Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company | 05/05/2010 |
The securities of Mesoblast Limited (the "Company") will be reinstated to quotation immediately, following the release of an announcement by the Company. | 14/06/2016 |
The company provides an update on its global heart failure program. | 14/06/2016 |
The company advises that the suspension of trading in its securities will remain in place pending an announcement regarding material corporate developments with respect to certain assets of the Company. The Company expects the voluntary suspension to remain in place until the earlier of the commencement of trading on 14 June 2016 and the Company making an announcement with respect to the corporate developments. | 10/06/2016 |
The securities of Mesoblast Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company. | 03/06/2016 |
The securities of Mesoblast Limited (the "Company") will be reinstated to quotation immediately, following the release of an announcement by the Company. Security Code: MSB | 16/11/2015 |
Mesoblast Limited (ASX:MSB; NASDAQ:MESO) today announced it had listed on the Nasdaq Global Market on 13 November under the symbol "˜MESO | 16/11/2015 |
Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today announced that it has filed a US registration statement on Form F-1 with the U.S. Securities and Exchange Commission, offering 5,742,510 American Depositary Shares (ADSs) in the United States, with each ADS representing five fully paid ordinary shares of Mesoblast (Shares). The actual number of ADSs and the issue price, in U.S. dollars, will be determined by Mesoblast in conjunction with the Company's underwriters at the conclusion of the offer process. | 03/11/2015 |
Mesoblast Limited (ASX: MSB, USOTC: MBLTY) announced today that it plans to conduct a registered initial public offering in the United States. Mesoblast has previously submitted to the U.S. Securities and Exchange Commission (the "SEC") a draft registration statement. Mesoblast intends to publicly file its registration statement with the SEC and commence the offering next week. | 30/10/2015 |
The company lodges its quarterly report. | 30/10/2015 |
The securities of Mesoblast Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company. Security Code: MSB | 30/10/2015 |
shares reinstated to quotation | 12/05/2010 |
the securities of Mesoblast Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company | 05/05/2010 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 18/03/2020 | Donal O'Dwyer | 85,250 | $1.177 | $100,298 |
| 03/12/2019 | William Burns | 32,670 | $1.830 | $59,786 |
| 30/11/2015 | Ben-Zion Weiner | 48,000 | $1.128 | $54,129 |
| 24/11/2015 | William Burns | 28,000 | $1.760 | $49,355 |
| 20/11/2015 | Brian Jamieson | 15,000 | $1.799 | $26,998 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Joseph Swedish | Non Exec Chairman | 19/06/2018 |
| Donal O'Dwyer | Deputy Chairman, Non Exec Director | 29/09/2004 |
| William Burns | Vice Chairman | 06/03/2014 |
| Silviu Itescu | Managing Director, CEO | 08/06/2004 |
| Dagmar Rosa-Bjorkeson | COO | 24/07/2020 |
| Paul Hodgkinson | CFO | 25/08/2014 |
| Josh Muntner | CFO | 31/05/2018 |
| Shawn Tomasello | Non Exec Director | 11/07/2018 |
| Michael Spooner | Non Exec Director | 15/08/2005 |
| Ben-Zion Weiner | Non Exec Director | 10/05/2012 |
| Philip Facchina | Director | 29/03/2021 |
| Eric Rose | Director | 17/04/2013 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Brian Jamieson | Non Exec Chairman | 22/11/2007 | 31/03/2019 |
| Jenni Pilcher | CFO | 01/11/2007 | 31/08/2014 |
| Kevin Buchi | Non Exec Director | 30/12/2010 | 09/05/2012 |
| Byron McAllister | Non Exec Director | 29/09/2004 | 29/11/2010 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2021 Investogain Pty Limited. All rights reserved.
